Jun Luo

Also affiliated with Johns Hopkins Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.282Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers

Cancers(2025)10.3390/cancers17091432

Top 57%

0.282DataRank

Top 57%5 citations

Ali T. Arafa, Ellen Jaeger, Stamatina Fragkogianni, Anne Sonnenschein, Elizabeth Mauer +5 more

Papers

Driven by 25 papers — median percentile 43. Top paper: “Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial”.

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

The Prostate(2021)10.1002/pros.24110

N/A

1.7DataRank · unranked

71 citations

Karim Boudadi, Wei Fu, Hao Wang, Rana Sullivan, Alice Jordan +12 more

Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer

JCI Insight(2021)10.1172/jci.insight.146827

N/A

1.5DataRank · unranked

58 citations

Yezi Zhu, Ilsa M. Coleman, Susan L. Dalrymple, Lizamma Antony, Radhika A. Patel +16 more

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.043

N/A

1.2DataRank · unranked

47 citations

Hao Wang, Su J. Lim ScM, Irina Rifkind, Nduku Ngomba, John T. Isaacs +10 more

Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors

Oncogene(2020)10.1038/s41388-020-01479-6

N/A

0.701DataRank · unranked

106 citations

Susan L. Dalrymple, Ilsa M. Coleman, Shun Zheng, Jianfeng Xu, Jody E. Hooper +10 more

Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer

The Journal of Pathology(2021)10.1002/path.5781

N/A

0.550DataRank · unranked

38 citations

Alba FC Torres, Juhyung Woo, Thiago Vidotto, Harrison Tsai, Jun Luo +9 more

Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3471

N/A

0.546DataRank · unranked

37 citations

Susan Halabi, Joseph D. Schonhoft, Qian Yang, Jun Luo, David M. Nanus +19 more

The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3017

N/A

0.406DataRank · unranked

14 citations

Siyuan Guo, Joseph J. Park, David M. Nanus, Daniel J. George, Emmanuel S. Antonarakis +8 more

Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers

Cancers(2025)10.3390/cancers17091432

Top 57%

0.282DataRank

Top 57%5 citations

Ali T. Arafa, Ellen Jaeger, Stamatina Fragkogianni, Anne Sonnenschein, Elizabeth Mauer +5 more

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.183

N/A

0.165DataRank · unranked

2 citations

Susan Halabi, Joseph D. Schonhoft, Jun Luo, David M. Nanus, Paraskevi Giannakakou +13 more

RESTORE: A single-arm, open-label phase II trial of bipolar androgen therapy (BAT) in men with metastatic castration resistant prostate cancer (mCRPC)—A comparison of post-abiraterone (Abi) versus post-enzalutamide (Enza) patients (Pts).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5576

N/A

0.104DataRank · unranked

1 citations

Hao Wang, Michael T. Schweizer, Michael A. Carducci, Channing J. Paller, Benjamin A. Teply +5 more

Characterization of HOXB13 expression patterns in localized and metastatic castration‐resistant prostate cancer

The Journal of Pathology(2023)10.1002/path.6216

N/A

0DataRank · unranked

26 citations

Erolcan Sayar, Ilsa Coleman, Martine P. Roudier, Brian Hanratty, Jin‐Yih Low +23 more

Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.09.012

N/A

0DataRank · unranked

11 citations

Yidong Chen, Daniel Rabizadeh, Lauren Vera, Changxue Lu, Sarah M. Nielsen +7 more

Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer

The Prostate(2024)10.1002/pros.24712

N/A

0DataRank · unranked

17 citations

Lukasz P. Gondek, В. Даниэльс, Changxue Lu, Sergiu Paşca, Jiajun Xie +7 more

Therapeutic Approaches to Targeting Androgen Receptor Splice Variants

Cells(2024)10.3390/cells13010104

N/A

0DataRank · unranked

14 citations

Jun Luo, Channing J. Paller, Mayuko Kanayama, В. Даниэльс

Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models

The Prostate(2024)10.1002/pros.24707

N/A

0DataRank · unranked

12 citations

Adel Mandl, Timothy Krueger, Susan L. Dalrymple, Lizamma Antony, Jennifer Dias +16 more

Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer

Neoplasia(2025)10.1016/j.neo.2025.101181

N/A

0DataRank · unranked

0 citations

Stephen J. Libertini, Salma Siddiqui, Maitreyee K. Jathal, Blythe Durbin‐Johnson, Clifford G. Tepper +6 more

Regulation of androgen receptor variants in prostate cancer

Asian journal of urology(2020)10.1016/j.ajur.2020.01.001

N/A

0DataRank · unranked

26 citations

Jun Luo, Yezi Zhu

AR-V7 and prediction of benefit with taxane therapy: Final analysis of PROPHECY.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.184

N/A

0DataRank · unranked

1 citations

Jun Luo, Monika Anand, Emmanuel S. Antonarakis, David M. Nanus, Paraskevi Giannakakou +10 more

Mechanical Unloading is Associated with Decreased DNA Content in Cardiomyocytes Independent of Nucleation State

medRxiv(2020)10.1101/2020.12.18.20248510

N/A

0DataRank · unranked

1 citations

Stephen Farris, Deri Helterline, April Stempien‐Otero, Jun Luo

AR Splicing Variants and Resistance to AR Targeting Agents

Cancers(2021)10.3390/cancers13112563

N/A

0DataRank · unranked

65 citations

Changxue Lu, Jun Luo, Emmanuel S. Antonarakis, Mayuko Kanayama

Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies

Cancer Research(2022)10.1158/0008-5472.can-22-0985

N/A

0DataRank · unranked

49 citations

Lukasz P. Gondek, Jun Luo, Emmanuel S. Antonarakis, Catherine H. Marshall

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Cancer Research(2022)10.1158/0008-5472.can-22-1533

N/A

0DataRank · unranked

22 citations

Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri +14 more

Prostate cancer androgen receptor activity dictates efficacy of Bipolar Androgen Therapy

medRxiv(2022)10.1101/2022.04.26.22274275

N/A

0DataRank · unranked

4 citations

Rajendra Kumar, David E. Sanin, Elizabeth A. Thompson, Dina Rosen, Susan L. Dalrymple +20 more

Polo-like kinase-1 Inhibitors and the Antiandrogen Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491633

N/A

0DataRank · unranked

0 citations

Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri +14 more

Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.100937

N/A

0DataRank · unranked

29 citations

Sandra Santasusagna, Perumalraja Kirthika, Michael Xu, Peiyao Li, Marc Carceles‐Cordon +16 more

Jun Luo

Indexed papers

Top data-sharing exemplar

Papers